Association study of SNAP25 and schizophrenia in Irish family and case-control samples

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 2, 2010, Pages 663-674

  Fanous, A H ^a,b,c   Zhao, Z ^d   Van Den Oord, E J C G ^c,e   Maher, B S ^c   Thiselton, D L ^c   Bergen, S E ^c   Wormley, B ^c   Bigdeli, T ^c   Amdur, R L ^a,b   O'Neill, F A ^f   Walsh, D ^g   Kendler, K S ^c,e   Riley, B P ^c,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^g HEALTH RESEARCH BOARD   (Ireland)

Author keywords

Association; Clinical features; Polymorphism; Schizophrenia; SNAP25

Indexed keywords

DNA; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PEDIGREE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEQUENCE TAGGED SITE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; AXONS; CASE-CONTROL STUDIES; DENDRITES; FAMILY HEALTH; GENETIC MARKERS; HAPLOTYPES; HUMANS; IRELAND; MODELS, GENETIC; PHENOTYPE; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25;

EID: 77349086395     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31037     Document Type: Article

References (70)

1. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. 2002. Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30:97-101.
2. Angrist B, Rotrosen J, Gershon S. 1980. Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology (Berl) 72:17-19.
3. Arinami T, Ohtsuki T, Ishiguro H, Ujike H, Tanaka Y, Morita Y, Mineta M, Takeichi M, Yamada S, Imamura A, Ohara K, Shibuya H, Ohara K, Suzuki Y, Muratake T, Kaneko N, Someya T, Inada T, Yoshikawa T, Toyota T, Yamada K, Kojima T, Takahashi S, Osamu O, Shinkai T, Nakamura M, Fukuzako H, Hashiguchi T, Niwa SI, Ueno T, Tachikawa H, Hori T, Asada T, Nanko S, Kunugi H, Hashimoto R, Ozaki N, Iwata N, Harano M, Arai H, Ohnuma T, Kusumi I, Koyama T, Yoneda H, Fukumaki Y, Shibata H, Kaneko S, Higuchi H, Yasui-Furukori N, Numachi Y, Itokawa M, Okazaki Y. 2005. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet 77: 937-944.
4. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
5. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 57: 289-300.
6. Benjamini Y, Hochberg Y. 2000. On the adaptive control of the false discovery rate in multiple testing with independent statistics. J Educ Behav Stat 25:60-83.
7. Berrios GE. 1995. Unitary psychosis concept. In: Berrios GE, Porter R, editors. A history of clinical psychiatry. London: The Athlone Press. p 313-335.
8. Brameier M, Wiuf C. 2007. Ab initio identification of human microRNAs based on structure motifs. BMC Bioinformatics 8:478.
9. Brophy K, Hawi Z, Kirley A, Fitzgerald M, Gill M. 2002. Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): Evidence of linkage and association in the Irish population. Mol Psychiatry 7:913-917.
10. Brown BW, Russell K. 1997. Methods of correcting for multiple testing: Operating characteristics. Stat Med 16:2511-2528.
11. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. 2005. MatInspector and beyond: Promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933-2942.
12. Couronne O, Poliakov A, Bray N, Ishkhanov T, Ryaboy D, Rubin E, Pachter L, Dubchak I. 2003. Strategies and tools for whole-genome alignments. Genome Res 13:73-80.
13. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115-121.
14. Fanous AH, Kendler KS. 2005. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: Searching for a framework. Mol Psychiatry 10:6-13.
15. Fanous AH, Kendler KS. 2008. Genetics of clinical features and subtypes of schizophrenia: A review of the recent literature. Curr Psychiatry Rep 10:164-170.
16. Fanous AH, Van Den Oord EJ, Riley BP, Aggen SH, Neale MC, O'Neill FA, Walsh D, Kendler KS. 2005. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am J Psychiatry 162:1824-1832.
17. Fanous AH, Neale MC, Webb BT, Straub RE, O'Neill FA, Walsh D, Riley BP, Kendler KS. 2008. Novel linkage to chromosome 20p using latent classes of psychotic illness in 270 Irish high-density families. Biol Psychiatry 64:121-127.
18. Fatemi SH, Earle JA, Stary JM, Lee S, Sedgewick J. 2001. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport 12:3257-3262.
19. Feng Y, Crosbie J, Wigg K, Pathare T, Ickowicz A, Schachar R, Tannock R, Roberts W, Malone M, Swanson J, Kennedy JL, Barr CL. 2005. The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol Psychiatry 10:998-1005, 973.
20. Fernando RL, Nettleton D, Southey BR, Dekkers JC, Rothschild MF, Soller M. 2004. Controlling the proportion of false positives in multiple dependent tests. Genetics 166:611-619.
21. Gabriel SM, Haroutunian V, Powchik P, Honer WG, Davidson M, Davies P, Davis KL. 1997. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. Arch Gen Psychiatry 54:559-566.
22. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. 2002. The structure of haplotype blocks in the human genome. Science 296:2225-2229.
23. Goto Y, Otani S, Grace AA. 2007. The Yin and Yang of dopamine release: A new perspective. Neuropharmacology 53:583-587.
24. Graham ME, Washbourne P, Wilson MC, Burgoyne RD. 2002. Molecular analysis of SNAP-25 function in exocytosis. Ann NY Acad Sci 971:210-221.
25. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10:40-68.
26. Hetey L, Schwitzkowsky R, Ott T, Barz H. 1991. Diminished synaptosomal dopamine (DA) release and DA autoreceptor supersensitivity in schizophrenia. J Neural Transm Gen Sect 83:25-35.
27. Jeans AF, Oliver PL, Johnson R, Capogna M, Vikman J, Molnar Z, Babbs A, Partridge CJ, Salehi A, Bengtsson M, Eliasson L, Rorsman P, Davies KE. 2007. A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse. Proc Natl Acad Sci USA 104:2431-2436.
28. Karson CN, Mrak RE, Schluterman KO, Sturner WQ, Sheng JG, Griffin WS. 1999. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: A possible neurochemical basis for 'hypofrontality'. Mol Psychiatry 4:39-45.
29. Kendler KS, McGuire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. 1993. The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry 50:527-540.
30. Keshavan MS, Sujata M, Mehra A, Montrose DM, Sweeney JA. 2003. Psychosis proneness and ADHD in young relatives of schizophrenia patients. Schizophr Res 59:85-92.
31. Keshavan M, Montrose DM, Rajarethinam R, Diwadkar V, Prasad K, Sweeney JA. 2008. Psychopathology among offspring of parents with schizophrenia: Relationship to premorbid impairments. Schizophr Res 103:114-120.
32. Kim JW, Biederman J, Arbeitman L, Fagerness J, Doyle AE, Petty C, Perlis RH, Purcell S, Smoller JW, Faraone SV, Sklar P. 2007. Investigation of variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder. Am J Med Genet Part B 144B:781-790.
33. Kimura K, Mizoguchi A, Ide C. 2003. Regulation of growth cone extension by SNARE proteins. J Histochem Cytochem 51:429-433.
34. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF. 2004. Molecular abnormalities of the hippocampus in severe psychiatric illness: Postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 9:609-620, 544.
35. Korn EL, Troendle J, McShane L, Simon R. 2004. Controlling the numberof false discoveries: Application to high-dimensional genomic data. J Stat Plann Inference 124:379-398.
36. Laird NM, Horvath S, Xu X. 2000. Implementing a unified approach to family-based tests of association. Genet Epidemiol 19(Suppl1):S36-S42.
37. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lonnqvist J, Peltonen L, O'Donovan MC, Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G, McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E, Zoega T, Helgason T. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 73:34-48.
38. Ludolph AG, Kassubek J, Schmeck K, Glaser C, Wunderlich A, Buck AK, Reske SN, Fegert JM, Mottaghy FM. 2008. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treatedandnever treated young adults: A 3,4-dihdroxy-6-[(18)F]fluorophenyl-l- alanine PET study. Neuroimage 41:718-727.
39. Macgregor S, Craddock N, Holmans PA. 2006. Use of phenotypic covariates in association analysis by sequential addition of cases. Eur J Hum Genet 14:529-534.
40. Martin ER, Monks SA, Warren LL, Kaplan NL. 2000. A test for linkage and association in general pedigrees: The pedigree disequilibrium test. Am J Hum Genet 67:146-154.
41. McGuffin P, Farmer A, Harvey I. 1991. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 48:764-770.
42. Mill J, Richards S, Knight J, Curran S, Taylor E, Asherson P. 2004. Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol Psychiatry 9:801-810.
43. Mill J, Xu X, Ronald A, Curran S, Price T, Knight J, Craig I, Sham P, Plomin R, Asherson P. 2005. Quantitative trait locus analysis of candidate gene alleles associated with attention deficit hyperactivity disorder (ADHD) in five genes: DRD4, DAT1, DRD5, SNAP-25, and 5HT1B. Am J Med Genet Part B 133B:68-73.
44. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F, Arolt V, Blackwood D, Liu X, Sjogren B. 1995. Aninternational two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet 11:321-324.
45. Nam JW, Kim J, Kim SK, Zhang BT. 2006. ProMiR II: A web server for the probabilistic prediction of clustered, nonclustered, conserved and nonconserved microRNAs. Nucleic Acids Res 34:W455-W458.
46. Numakawa T, Yagasaki Y, Ishimoto T, Okada T, Suzuki T, Iwata N, Ozaki N, Taguchi T, Tatsumi M, Kamijima K, Straub RE, Weinberger DR, Kunugi H, Hashimoto R. 2004. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 13:2699-2708.
47. O'Connell JR, Weeks DE. 1998. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63:259-266.
48. Osen-Sand A, Catsicas M, Staple JK, Jones KA, Ayala G, Knowles J, Grenningloh G, Catsicas S. 1993. Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature 364:445-448.
49. Renner TJ, Walitza S, Dempfle A, Eckert L, Romanos M, Gerlach M, Schafer H, Warnke A, Lesch KP, Jacob C. 2008. Allelic variants of SNAP25 in a family-based sample of ADHD. J Neural Transm 115:317-321.
50. Riley B, Kendler KS. 2006. Molecular genetic studies of schizophrenia. Eur J Hum Genet 14:669-680.
51. Sabatti C, Service S, Freimer N. 2003. False discovery rate in linkage and association genome screens for complex disorders. Genetics 164:829-833.
52. SAS Institute. 1999. SAS/STAT Software, version 8. Cary, N.C.: SAS Institute.
53. Sherman AD, Hegwood TS, Baruah S, Waziri R. 1991. Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics. Biol Psychiatry 30:1191-1198.
54. Spitzer RL, Williams JB, Gibbon J. 1987. Structured clinical interview for DSM-III-R patient version. New York: New York Psychiatric Institute.
55. Storey J. 2003. The positive false discovery rate: A Bayesian interpretation and the q-value. Ann Stat 31:2013-2035.
56. Storey J, Tibshirani R. 2003. Statistical significance for genome-wide studies. Proc Natl Acad Sci 100:9440-9445.
57. Straub RE, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, O'Neill FA, Walsh D, Kendler KS. 2002. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol Psychiatry 7:542-559.
58. Sweet RA, Bergen SE, Sun Z, Marcsisin MJ, Sampson AR, Lewis DA. 2007. Anatomical evidence of impaired feedforward auditory processing in schizophrenia. Biol Psychiatry 61:854-864.
59. Tachikawa H, Harada S, Kawanishi Y, Okubo T, Suzuki T. 2001. Polymorphism of the 5′-upstream region of the human SNAP-25 gene: An association analysis with schizophrenia. Neuropsychobiology 43:131-133.
60. Thompson PM, Sower AC, Perrone-Bizzozero NI. 1998. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol Psychiatry 43:239-243.
61. Thompson PM, Rosenberger C, Qualls C. 1999. CSF SNAP-25 in schizophrenia and bipolar illness. A pilot study. Neuropsychopharmacology 21:717-722.
62. Thompson PM, Egbufoama S, Vawter MP. 2003a. SNAP-25 reduction in the hippocampus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27:411-417.
63. Thompson PM, Kelley M, Yao J, Tsai G, van Kammen DP. 2003b. Elevated cerebrospinal fluid SNAP-25 in schizophrenia. Biol Psychiatry 53:1132-1137.
64. Tsai CA, Hsueh HM, Chen JJ. 2003. Estimation of false discovery rates in multiple testing: Application to gene microarray data. Biometrics 59:1071-1081.
65. Van den Oord EJCG, Sullivan PF. 2003a. A framework for controlling false discovery rates and minimizing the amount of genotyping in the search for disease mutations. Hum Hered 56:188-199.
66. Van den Oord EJCG, Sullivan PF. 2003b. False discoveries and models for gene discovery. Trends Genet 19:537-542.
67. Van Den Oord EJ, Jiang Y, Riley BP, Kendler KS, Chen X. 2003. FP-TDI SNP scoring by manual and statistical procedures: A study of error rates and types. Biotechniques 34:610-620, 622.
68. Van den Oord EJCG. 2005. Controlling false discoveries in candidate gene studies. Mol Psychiatry 10:230-231.
69. Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J. 1992. Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry 49:959-965.
70. Young CE, Arima K, Xie J, Hu L, Beach TG, Falkai P, Honer WG. 1998. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex 8:261-268.